Indication

Oropharyngeal candidiasis

Oropharyngeal candidiasis, commonly referred to as oral thrush, is an opportunistic fungal infection affecting the mucosal lining of the oral cavity and pharynx. Read more about Oropharyngeal candidiasis

80 drugs 67 manufacturers

Advertisement

Drugs that treat it

Common Oropharyngeal candidiasis therapies.

Showing 19–27 of 80 drugs

FLUCONAZOLE

ANTIFUNGALS-SYSTEMIC·ORAL CANDIDIASIS·+11
GREENSTONE LLC.
Filter & compare in the drug finder →Opens the drug finder with Oropharyngeal candidiasis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Oropharyngeal candidiasis.

Oropharyngeal candidiasis, commonly referred to as oral thrush, is an opportunistic fungal infection affecting the mucosal lining of the oral cavity and pharynx.

It is primarily caused by an overgrowth of *Candida* species—most frequently *Candida albicans*—which naturally colonize the mucous membranes as commensal flora.

The condition predominantly develops when local or systemic immune defenses or normal microflora are disrupted, frequently impacting infants, denture wearers, individuals using broad-spectrum antibiotics or inhaled corticosteroids, and immunocompromised populations such as patients with HIV infection, hematologic malignancies, or diabetes mellitus.

Clinically, it is characterized by white, curdy pseudomembranous plaques that can be scraped off to reveal an erythematous base, often accompanied by oral mucosal erythema, local burning pain, dysgeusia, and dysphagia.

Personalize your experience

Follow Oropharyngeal candidiasis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it